Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
HLS's Cash to Debt is ranked lower than
73% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. HLS: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
HLS' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.06 Max: N/A
Current: 0.02
Equity to Asset 0.18
HLS's Equity to Asset is ranked lower than
87% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HLS: 0.18 )
Ranked among companies with meaningful Equity to Asset only.
HLS' s 10-Year Equity to Asset Range
Min: -0.77  Med: 0.13 Max: 0.59
Current: 0.18
-0.77
0.59
Interest Coverage 4.28
HLS's Interest Coverage is ranked lower than
64% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. HLS: 4.28 )
Ranked among companies with meaningful Interest Coverage only.
HLS' s 10-Year Interest Coverage Range
Min: 0.29  Med: 3.24 Max: 9999.99
Current: 4.28
0.29
9999.99
F-Score: 5
Z-Score: 1.48
M-Score: -2.47
WACC vs ROIC
7.45%
14.74%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 18.01
HLS's Operating margin (%) is ranked higher than
84% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.05 vs. HLS: 18.01 )
Ranked among companies with meaningful Operating margin (%) only.
HLS' s 10-Year Operating margin (%) Range
Min: -3.55  Med: 18.41 Max: 37.8
Current: 18.01
-3.55
37.8
Net-margin (%) 6.63
HLS's Net-margin (%) is ranked higher than
73% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. HLS: 6.63 )
Ranked among companies with meaningful Net-margin (%) only.
HLS' s 10-Year Net-margin (%) Range
Min: -36.52  Med: 4.80 Max: 48.3
Current: 6.63
-36.52
48.3
ROE (%) 35.43
HLS's ROE (%) is ranked higher than
97% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 8.45 vs. HLS: 35.43 )
Ranked among companies with meaningful ROE (%) only.
HLS' s 10-Year ROE (%) Range
Min: -22.44  Med: 15.76 Max: 1149.06
Current: 35.43
-22.44
1149.06
ROA (%) 5.61
HLS's ROA (%) is ranked higher than
75% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 3.44 vs. HLS: 5.61 )
Ranked among companies with meaningful ROA (%) only.
HLS' s 10-Year ROA (%) Range
Min: -17.98  Med: 5.15 Max: 44.36
Current: 5.61
-17.98
44.36
ROC (Joel Greenblatt) (%) 36.09
HLS's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. HLS: 36.09 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HLS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -29.05  Med: 37.58 Max: 51.02
Current: 36.09
-29.05
51.02
Revenue Growth (3Y)(%) 8.70
HLS's Revenue Growth (3Y)(%) is ranked higher than
55% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. HLS: 8.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HLS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -27  Med: -1.10 Max: 8.7
Current: 8.7
-27
8.7
EBITDA Growth (3Y)(%) 14.10
HLS's EBITDA Growth (3Y)(%) is ranked higher than
68% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. HLS: 14.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HLS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -3.80 Max: 19.8
Current: 14.1
0
19.8
EPS Growth (3Y)(%) 16.40
HLS's EPS Growth (3Y)(%) is ranked higher than
61% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. HLS: 16.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HLS' s 10-Year EPS Growth (3Y)(%) Range
Min: -47.9  Med: 6.90 Max: 56
Current: 16.4
-47.9
56
» HLS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

HLS Guru Trades in Q3 2014

Paul Tudor Jones 13,585 sh (+114.82%)
Jim Simons 971,400 sh (+23.71%)
Columbia Wanger 2,519,800 sh (-0.25%)
Mariko Gordon 1,857,733 sh (-0.31%)
Chuck Royce 756,513 sh (-5.00%)
James Barrow 2,401,883 sh (-16.91%)
» More
Q4 2014

HLS Guru Trades in Q4 2014

Joel Greenblatt 215,644 sh (New)
Paul Tudor Jones 21,680 sh (+59.59%)
Jim Simons 1,066,400 sh (+9.78%)
Chuck Royce 756,513 sh (unchged)
Mariko Gordon 1,851,856 sh (-0.32%)
Columbia Wanger 2,041,623 sh (-18.98%)
James Barrow 1,884,750 sh (-21.53%)
» More
Q1 2015

HLS Guru Trades in Q1 2015

Larry Robbins 1,700,753 sh (New)
Mariko Gordon 1,953,842 sh (+5.51%)
Columbia Wanger 2,107,000 sh (+3.20%)
Joel Greenblatt Sold Out
James Barrow 1,882,150 sh (-0.14%)
Jim Simons 1,053,100 sh (-1.25%)
Chuck Royce 538,013 sh (-28.88%)
Paul Tudor Jones 13,400 sh (-38.19%)
» More
2015

HLS Guru Trades in 2015

Larry Robbins 5,903,100 sh (+247.09%)
» More
» Details

Insider Trades

Latest Guru Trades with HLS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1557.374.206 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 26.01
HLS's P/E(ttm) is ranked higher than
69% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 29.60 vs. HLS: 26.01 )
Ranked among companies with meaningful P/E(ttm) only.
HLS' s 10-Year P/E(ttm) Range
Min: 1.71  Med: 11.54 Max: 32.2
Current: 26.01
1.71
32.2
Forward P/E 17.51
HLS's Forward P/E is ranked higher than
65% of the 92 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. HLS: 17.51 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.40
HLS's PE(NRI) is ranked higher than
66% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 29.10 vs. HLS: 25.40 )
Ranked among companies with meaningful PE(NRI) only.
HLS' s 10-Year PE(NRI) Range
Min: 1.84  Med: 13.65 Max: 181.64
Current: 25.4
1.84
181.64
P/B 7.88
HLS's P/B is ranked lower than
92% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. HLS: 7.88 )
Ranked among companies with meaningful P/B only.
HLS' s 10-Year P/B Range
Min: 6.91  Med: 8.66 Max: 191.71
Current: 7.88
6.91
191.71
P/S 1.77
HLS's P/S is ranked lower than
58% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. HLS: 1.77 )
Ranked among companies with meaningful P/S only.
HLS' s 10-Year P/S Range
Min: 0.4  Med: 1.16 Max: 3.95
Current: 1.77
0.4
3.95
PFCF 17.82
HLS's PFCF is ranked higher than
69% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 21.92 vs. HLS: 17.82 )
Ranked among companies with meaningful PFCF only.
HLS' s 10-Year PFCF Range
Min: 1.77  Med: 9.48 Max: 18.06
Current: 17.82
1.77
18.06
POCF 11.46
HLS's POCF is ranked higher than
75% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 15.63 vs. HLS: 11.46 )
Ranked among companies with meaningful POCF only.
HLS' s 10-Year POCF Range
Min: 1.53  Med: 6.41 Max: 11.6
Current: 11.46
1.53
11.6
EV-to-EBIT 14.13
HLS's EV-to-EBIT is ranked higher than
78% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 20.07 vs. HLS: 14.13 )
Ranked among companies with meaningful EV-to-EBIT only.
HLS' s 10-Year EV-to-EBIT Range
Min: -35.1  Med: 11.70 Max: 90.2
Current: 14.13
-35.1
90.2
PEG 1.68
HLS's PEG is ranked higher than
75% of the 65 Companies
in the Global Medical Care industry.

( Industry Median: 2.89 vs. HLS: 1.68 )
Ranked among companies with meaningful PEG only.
HLS' s 10-Year PEG Range
Min: 1.03  Med: 1.56 Max: 2.66
Current: 1.68
1.03
2.66
Shiller P/E 15.17
HLS's Shiller P/E is ranked higher than
87% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 31.19 vs. HLS: 15.17 )
Ranked among companies with meaningful Shiller P/E only.
HLS' s 10-Year Shiller P/E Range
Min: 5.2  Med: 10.58 Max: 40.86
Current: 15.17
5.2
40.86
Current Ratio 1.95
HLS's Current Ratio is ranked higher than
69% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. HLS: 1.95 )
Ranked among companies with meaningful Current Ratio only.
HLS' s 10-Year Current Ratio Range
Min: 0.6  Med: 1.85 Max: 6.95
Current: 1.95
0.6
6.95
Quick Ratio 1.95
HLS's Quick Ratio is ranked higher than
73% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. HLS: 1.95 )
Ranked among companies with meaningful Quick Ratio only.
HLS' s 10-Year Quick Ratio Range
Min: 0.6  Med: 1.85 Max: 6.95
Current: 1.95
0.6
6.95
Days Sales Outstanding 47.95
HLS's Days Sales Outstanding is ranked lower than
54% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.60 vs. HLS: 47.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLS' s 10-Year Days Sales Outstanding Range
Min: 40.54  Med: 45.81 Max: 89.44
Current: 47.95
40.54
89.44

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.79
HLS's Dividend Yield is ranked higher than
55% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. HLS: 1.79 )
Ranked among companies with meaningful Dividend Yield only.
HLS' s 10-Year Dividend Yield Range
Min: 0.5  Med: 1.79 Max: 2.09
Current: 1.79
0.5
2.09
Dividend Payout 0.49
HLS's Dividend Payout is ranked higher than
68% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. HLS: 0.49 )
Ranked among companies with meaningful Dividend Payout only.
HLS' s 10-Year Dividend Payout Range
Min: 0.21  Med: 0.40 Max: 0.52
Current: 0.49
0.21
0.52
Yield on cost (5-Year) 1.79
HLS's Yield on cost (5-Year) is ranked lower than
54% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 2.03 vs. HLS: 1.79 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HLS' s 10-Year Yield on cost (5-Year) Range
Min: 0.5  Med: 1.79 Max: 2.09
Current: 1.79
0.5
2.09
Share Buyback Rate 2.70
HLS's Share Buyback Rate is ranked higher than
94% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. HLS: 2.70 )
Ranked among companies with meaningful Share Buyback Rate only.
HLS' s 10-Year Share Buyback Rate Range
Min: 2.7  Med: -1.90 Max: -31.9
Current: 2.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.21
HLS's Price/Projected FCF is ranked higher than
67% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 1.62 vs. HLS: 1.21 )
Ranked among companies with meaningful Price/Projected FCF only.
HLS' s 10-Year Price/Projected FCF Range
Min: 0.57  Med: 1.77 Max: 209.14
Current: 1.21
0.57
209.14
Price/Median PS Value 1.53
HLS's Price/Median PS Value is ranked lower than
75% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. HLS: 1.53 )
Ranked among companies with meaningful Price/Median PS Value only.
HLS' s 10-Year Price/Median PS Value Range
Min: 0.41  Med: 1.16 Max: 3.36
Current: 1.53
0.41
3.36
Price/Peter Lynch Fair Value 1.80
HLS's Price/Peter Lynch Fair Value is ranked higher than
74% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.15 vs. HLS: 1.80 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HLS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.1  Med: 1.45 Max: 5.91
Current: 1.8
0.1
5.91
Earnings Yield (Greenblatt) (%) 7.12
HLS's Earnings Yield (Greenblatt) (%) is ranked higher than
83% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. HLS: 7.12 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HLS' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.1  Med: 8.30 Max: 16.5
Current: 7.12
1.1
16.5
Forward Rate of Return (Yacktman) (%) 19.58
HLS's Forward Rate of Return (Yacktman) (%) is ranked higher than
78% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. HLS: 19.58 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HLS' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 3.2  Med: 11.90 Max: 26.7
Current: 19.58
3.2
26.7

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 2,966 3,171 3,317
EPS($) 2.28 2.63 2.81
EPS without NRI($) 2.28 2.63 2.81

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, DVA, FSNUY, BDUUF, SKHCY » details
Traded in other countries:HSRPP.USA, HSOA.Germany,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.
» More Articles for HLS

Headlines

Articles On GuruFocus.com
Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
26.25% Annual Return With Lobbying Stocks? Here Is How It Works Nov 21 2014 
5 Stocks Building Long-Term Wealth With Increased Dividends Jul 28 2014 
"Thrift, fearlessness, resilience, hard work" - What Makes Mariko Gordon Our Newest Guru Dec 07 2013 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
physical therepy Jan 09 2013 
physical therepy Jan 09 2013 
HEALTHSOUTH Corp. Reports Operating Results (10-K) Feb 24 2011 
HealthSouth Reports Results for Second Quarter 2009 and Increases 2009 Guidance Aug 04 2009 
HealthSouth Declares Dividend on 6.5 Percent Series A Convertible Perpetual Preferred Stock Dec 18 2008 

More From Other Websites
HealthSouth Announces Pricing of $350 Million of Senior Notes in a Private Offering Aug 04 2015
7:55 am Healthsouth announces a $300 mln private offering of 5.75% senior notes due 2024 Aug 04 2015
HealthSouth Announces Private Offering Of Senior Notes Aug 04 2015
HEALTHSOUTH CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 04 2015
10-Q for HealthSouth Corp. Aug 01 2015
Glenview Capital Boosts Stake in HealthSouth Corp (HLS) to 6.5% Aug 01 2015
Edited Transcript of HLS earnings conference call or presentation 30-Jul-15 1:00pm GMT Jul 30 2015
HealthSouth Corporation -- Moody's rates HealthSouth's new credit facilities Baa3; downgrades sr.... Jul 30 2015
Busy 2Q translates to strong revenue increase for HealthSouth Jul 30 2015
HEALTHSOUTH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 30 2015
HealthSouth meets 2Q profit forecasts Jul 29 2015
HealthSouth meets 2Q profit forecasts Jul 29 2015
HEALTHSOUTH CORP Files SEC form 8-K, Results of Operations and Financial Condition Jul 29 2015
HealthSouth Reports Results for Second Quarter 2015 Jul 29 2015
Q2 2015 HealthSouth Corp Earnings Release - After Market Close Jul 29 2015
Q2 2015 Earnings Conference Call Jul 28 2015
HEALTHSOUTH CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 20 2015
HealthSouth Announces Retirement Of John Whittington Jul 20 2015
HealthSouth Increases And Declares Dividend On Common Stock Jul 16 2015
HealthSouth Announces Date of 2015 Second Quarter Earnings Conference Call Jul 08 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK